Annual Cash & Cash Equivalents
$23.87 M
-$3.40 M-12.47%
December 31, 2023
Summary
- As of February 7, 2025, AQST annual cash & cash equivalents is $23.87 million, with the most recent change of -$3.40 million (-12.47%) on December 31, 2023.
- During the last 3 years, AQST annual cash & cash equivalents has fallen by -$7.93 million (-24.95%).
- AQST annual cash & cash equivalents is now -60.61% below its all-time high of $60.60 million, reached on December 31, 2018.
Performance
AQST Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$77.89 M
-$11.98 M-13.33%
September 30, 2024
Summary
- As of February 7, 2025, AQST quarterly cash and cash equivalents is $77.89 million, with the most recent change of -$11.98 million (-13.33%) on September 30, 2024.
- Over the past year, AQST quarterly cash and cash equivalents has increased by +$52.98 million (+212.61%).
- AQST quarterly cash and cash equivalents is now -18.18% below its all-time high of $95.20 million, reached on March 31, 2024.
Performance
AQST Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AQST Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.5% | +212.6% |
| 3 y3 years | -24.9% | +212.6% |
| 5 y5 years | -60.6% | +212.6% |
AQST Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.8% | at low | -18.2% | +428.6% |
| 5 y | 5-year | -51.6% | at low | -18.2% | +428.6% |
| alltime | all time | -60.6% | +159.2% | -18.2% | +632.2% |
Aquestive Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $77.89 M(-13.3%) |
| Jun 2024 | - | $89.87 M(-5.6%) |
| Mar 2024 | - | $95.20 M(+298.8%) |
| Dec 2023 | $23.87 M(-12.5%) | $23.87 M(-4.2%) |
| Sep 2023 | - | $24.92 M(+11.1%) |
| Jun 2023 | - | $22.44 M(-16.5%) |
| Mar 2023 | - | $26.88 M(-1.4%) |
| Dec 2022 | $27.27 M(-2.7%) | $27.27 M(+46.2%) |
| Sep 2022 | - | $18.65 M(+5.4%) |
| Jun 2022 | - | $17.70 M(+20.1%) |
| Mar 2022 | - | $14.74 M(-47.4%) |
| Dec 2021 | $28.02 M | $28.02 M(-10.1%) |
| Sep 2021 | - | $31.16 M(-9.0%) |
| Jun 2021 | - | $34.23 M(+24.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $27.50 M(-13.5%) |
| Dec 2020 | $31.81 M(-35.5%) | $31.81 M(+86.4%) |
| Sep 2020 | - | $17.06 M(-32.9%) |
| Jun 2020 | - | $25.42 M(-28.4%) |
| Mar 2020 | - | $35.52 M(-28.0%) |
| Dec 2019 | $49.33 M(-18.6%) | $49.33 M(+135.9%) |
| Sep 2019 | - | $20.91 M(-5.6%) |
| Jun 2019 | - | $22.16 M(-44.5%) |
| Mar 2019 | - | $39.93 M(-34.1%) |
| Dec 2018 | $60.60 M(+248.7%) | $60.60 M(-5.3%) |
| Sep 2018 | - | $63.98 M(+501.4%) |
| Jun 2018 | - | $10.64 M(-35.5%) |
| Mar 2018 | - | $16.49 M(-5.1%) |
| Dec 2017 | $17.38 M(+88.7%) | $17.38 M |
| Dec 2016 | $9.21 M | - |
FAQ
- What is Aquestive Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Aquestive Therapeutics?
- What is Aquestive Therapeutics annual cash & cash equivalents year-on-year change?
- What is Aquestive Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Aquestive Therapeutics?
- What is Aquestive Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Aquestive Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of AQST is $23.87 M
What is the all time high annual cash & cash equivalents for Aquestive Therapeutics?
Aquestive Therapeutics all-time high annual cash & cash equivalents is $60.60 M
What is Aquestive Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, AQST annual cash & cash equivalents has changed by -$3.40 M (-12.47%)
What is Aquestive Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AQST is $77.89 M
What is the all time high quarterly cash and cash equivalents for Aquestive Therapeutics?
Aquestive Therapeutics all-time high quarterly cash and cash equivalents is $95.20 M
What is Aquestive Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, AQST quarterly cash and cash equivalents has changed by +$52.98 M (+212.61%)